127 related articles for article (PubMed ID: 10708301)
21. Development of oral self nano-emulsifying delivery system(s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions.
Ijaz M; Bonengel S; Zupančič O; Yaqoob M; Hartl M; Hussain S; Huck CW; Bernkop-Schnürch A
Expert Opin Drug Deliv; 2016 Jul; 13(7):923-9. PubMed ID: 27020604
[TBL] [Abstract][Full Text] [Related]
22. Direct 99mTc-labeling of antibodies by sodium dithionite reduction, and role of ascorbate as a stabilizer in cysteine challenge.
Qi P; Muddukrishna SN; Torok-Both R; Rahn J; Chen A
Nucl Med Biol; 1996 Aug; 23(6):827-35. PubMed ID: 8940727
[TBL] [Abstract][Full Text] [Related]
23. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
24. Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targeting.
Heppeler A; André JP; Buschmann I; Wang X; Reubi JC; Hennig M; Kaden TA; Maecke HR
Chemistry; 2008; 14(10):3026-34. PubMed ID: 18246556
[TBL] [Abstract][Full Text] [Related]
25. Iodination and stability of somatostatin analogues: comparison of iodination techniques. A practical overview.
de Blois E; Chan HS; Breeman WA
Curr Top Med Chem; 2012; 12(23):2668-76. PubMed ID: 23339762
[TBL] [Abstract][Full Text] [Related]
26. Breaking a Couple: Disulfide Reducing Agents.
Mthembu SN; Sharma A; Albericio F; de la Torre BG
Chembiochem; 2020 Jul; 21(14):1947-1954. PubMed ID: 32196882
[TBL] [Abstract][Full Text] [Related]
27. Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.
Sobal G; Resch U; Tatzber F; Sinzinger H
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):334-43. PubMed ID: 17043631
[TBL] [Abstract][Full Text] [Related]
28. Studies on the labeling of streptokinase with 99mTc for use as a radiopharmaceutical in the detection of deep-vein thrombosis: concise communication.
Duffy MJ; Duffy GJ
J Nucl Med; 1977 May; 18(5):483-5. PubMed ID: 16092
[TBL] [Abstract][Full Text] [Related]
29. Selective uptake of the somatostatin analog RC-160 across the blood-brain tumor barrier of mice with KHT sarcomas.
Banks WA; Kastin AJ; Radulovic S; Conley FK; Johnson DL; Schally AV
Anticancer Drugs; 1992 Oct; 3(5):519-23. PubMed ID: 1360272
[TBL] [Abstract][Full Text] [Related]
30. Synthetic model proteins: contribution of hydrophobic residues and disulfide bonds to protein stability.
Hodges RS; Zhou NE; Kay CM; Semchuk PD
Pept Res; 1990; 3(3):123-37. PubMed ID: 2134057
[TBL] [Abstract][Full Text] [Related]
31. The influence of carrier on 99mTc radiopharmaceuticals.
Ballinger JR
Q J Nucl Med; 2002 Sep; 46(3):224-32. PubMed ID: 12134138
[TBL] [Abstract][Full Text] [Related]
32. New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
Blok D; Feitsma HI; Kooy YM; Welling MM; Ossendorp F; Vermeij P; Drijfhout JW
Nucl Med Biol; 2004 Aug; 31(6):815-20. PubMed ID: 15246374
[TBL] [Abstract][Full Text] [Related]
33. Thiol-Disulfide Exchange in Human Growth Hormone.
Chandrasekhar S; Moorthy BS; Xie R; Topp EM
Pharm Res; 2016 Jun; 33(6):1370-82. PubMed ID: 26887678
[TBL] [Abstract][Full Text] [Related]
34. Characterization of cyclic peptides containing disulfide bonds.
Johnson M; Liu M; Struble E; Hettiarachchi K
J Pharm Biomed Anal; 2015 May; 109():112-20. PubMed ID: 25778927
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
[TBL] [Abstract][Full Text] [Related]
36. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
37. Lanreotide labeled with 99mTc: preparation, preclinical testing and comparison with (111)In-DTPA-octreotide.
Laznicek M; Laznickova A; Trejtnar F; Lorenc P; Varvarigou A; Bouziotis P; Archimandritis S
Anticancer Res; 2002; 22(4):2125-30. PubMed ID: 12174893
[TBL] [Abstract][Full Text] [Related]
38. Determination of Sn(II) in technetium cold kits by voltammetry at the hanging mercury drop electrode (HMDE) and relevant radiopharmaceutical applications.
Decristoforo C; Obendorf D; Reichart E; Stubauer G; Riccabona G
Nucl Med Biol; 1998 Oct; 25(7):675-83. PubMed ID: 9804049
[TBL] [Abstract][Full Text] [Related]
39. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.
Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S
Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the phytic acid effect on the labeling of blood elements with technetium-99m and on the survival of a strain of Escherichia coli treated with stannous fluoride.
Lima-Filho GL; Lima GM; Freitas RS; Aleixo LC; Moreno SR; Catanho MT; Bernardo-Filho M
Mol Cell Biochem; 2003 May; 247(1-2):121-6. PubMed ID: 12841639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
